Citigroup Inc Third Harmonic Bio, Inc. Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
A detailed history of Citigroup Inc transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Citigroup Inc holds 14,220 shares of THRD stock, worth $76,503. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,220
Previous 15,843
10.24%
Holding current value
$76,503
Previous $54,000
42.59%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding THRD
# of Institutions
102Shares Held
38.4MCall Options Held
62.7KPut Options Held
119K-
Atlas Venture Life Science Advisors, LLC10.4MShares$56 Million12.42% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$31.1 Million1.12% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.82MShares$20.6 Million15.71% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.94MShares$15.8 Million0.7% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.92MShares$10.3 Million2.12% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $217M